Invivyd, Inc. (IVVD)
0.6636
+0.06
(+9.18%)
USD |
NASDAQ |
Oct 15, 16:00
0.679
+0.02
(+2.32%)
After-Hours: 20:00
Invivyd Price to Book Value : 1.080 for Oct. 15, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 14, 2026 | 0.9894 |
| October 13, 2026 | 1.052 |
| October 12, 2026 | 1.096 |
| October 09, 2026 | 1.174 |
| October 08, 2026 | 1.140 |
| October 07, 2026 | 1.186 |
| October 06, 2026 | 1.313 |
| October 05, 2026 | 1.366 |
| October 02, 2026 | 1.338 |
| October 01, 2026 | 1.329 |
| September 30, 2026 | 1.416 |
| September 29, 2026 | 1.384 |
| September 28, 2026 | 1.546 |
| September 25, 2026 | 1.521 |
| September 24, 2026 | 1.487 |
| September 23, 2026 | 1.503 |
| September 22, 2026 | 1.569 |
| September 21, 2026 | 1.660 |
| September 18, 2026 | 1.229 |
| September 17, 2026 | 1.215 |
| September 16, 2026 | 1.311 |
| September 15, 2026 | 1.351 |
| September 14, 2026 | 1.452 |
| September 11, 2026 | 1.279 |
| September 10, 2026 | 1.263 |
| Date | Value |
|---|---|
| September 09, 2026 | 1.298 |
| September 08, 2026 | 1.344 |
| September 04, 2026 | 1.344 |
| September 03, 2026 | 1.359 |
| September 02, 2026 | 1.309 |
| September 01, 2026 | 1.432 |
| August 31, 2026 | 1.554 |
| August 28, 2026 | 1.57 |
| August 27, 2026 | 1.465 |
| August 26, 2026 | 1.468 |
| August 25, 2026 | 1.528 |
| August 24, 2026 | 1.534 |
| August 21, 2026 | 1.622 |
| August 20, 2026 | 1.548 |
| August 19, 2026 | 1.562 |
| August 18, 2026 | 1.413 |
| August 17, 2026 | 1.205 |
| August 14, 2026 | 1.174 |
| August 13, 2026 | 1.116 |
| August 12, 2026 | 1.192 |
| August 11, 2026 | 1.119 |
| August 10, 2026 | 1.096 |
| August 07, 2026 | 1.204 |
| August 06, 2026 | 1.073 |
| August 05, 2026 | 0.9838 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.07 |
| Anika Therapeutics, Inc. | 2.019 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.170 |
Price to Book Value Related Metrics
| PS Ratio | 3.076 |
| Price | 0.6636 |
| Earnings Yield | -56.21% |
| Market Cap | 195.60M |